Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01038921 · ClinicalTrials.gov registry record · Phase 2
Melatonin and the Metabolic Syndrome
A Phase 2 study, sponsored by Emory University.
- Completed
- Registry status
- Phase 2
- Development phase
- 39
- Enrollment target
NCT01038921 is a Phase 2 study that has completed, run by Emory University. The registered enrollment target is 39 participants.
The verdict
NCT01038921, a Phase 2 study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 39 participants
- Enrollment target
Study Summary
This trial seeks to compare the effects of melatonin supplementation versus placebo in subjects with the metabolic syndrome.
Interventions
- DRUG Placebo
- DRUG Melatonin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2009-07 |
| Est. Completion | 2013-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01038921
The ClinicalTrials.gov registry entry for NCT01038921 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01038921 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01038921 about?
NCT01038921 is a clinical study titled "Melatonin and the Metabolic Syndrome". This trial seeks to compare the effects of melatonin supplementation versus placebo in subjects with the metabolic syndrome.
What is the current status of trial NCT01038921?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 39 participants. The study started on 2009-07. Estimated completion is 2013-07.
What interventions are being tested in trial NCT01038921?
The interventions under investigation include: Placebo (DRUG), Melatonin (DRUG).
Who is sponsoring clinical trial NCT01038921?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.